At this point I'm willing to bet that a full Phase III trial will be required. There is just not enough data on the table to warrant approval at this time.
- Forums
- ASX - By Stock
- ropren concerns need to be addressed
At this point I'm willing to bet that a full Phase III trial...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SLA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online